Duke researchers have created a new antibody that helps the immune system find and attack cancer cells and virus-infected cells that try to hide by using a molecule called HLA-E. In early lab and mouse studies, the antibody boosted immune cells' ability to destroy these hidden diseased cells, raising hopes for a new treatment approach against both cancer and certain viral infections.

Duke University School of Medicineresearcher Amy Gladfelter studies fungal cells to uncover clues about everything from disease and pregnancy to how organisms adapt to stress.

A new Duke-led center, Duke AITC-AIGE, will help accelerate the safe and effective use of AI in aging and dementia care. Funded by the National Institute on Aging, it is one of five national collaboratories focused on advancing trustworthy AI for older adults and people living with dementia.

Duke researchers led by Bruce Sullenger, PhD, have developed both the first fast-acting, synthetic blood thinner that’s just as powerful as heparin, a medication that’s been used for heart surgeries and dialysis since 1935, and an antidote for the new drug.

Duke University School of Medicine postdoctoral researcher Drew Schreiner, PhD, has been named a 2026 STAT Wunderkind by STAT News for his work understanding how songbirds learn and develop their song. He is one of 28 early-career doctors and researchers in North America honored by the news outlet this year. 

Duke Health joined the Durham community to celebrate Pride: Durham, NC 2026. Duke showed its support at the event’s Pride Vendor & Food Truck Rodeo held at Durham Central Park on September 27.

Culture shapes how people move through the world, what they value, and often, the career paths they pursue.

Duke surgical oncologist Jennifer Plichta, MD, MS, is pushing the evolution of personalized care — combining data, research, and a deeply patient-centered approach to help patients navigate an increasingly complex landscape of breast cancer risk, prevention, and treatment.

Mary Klotman, MD, has decided to step down as dean of the Duke University School of Medicine and as executive vice president for health affairs at Duke University and chief academic officer f

Artificial intelligence is creating new opportunities to advance discovery, education, patient care, and the way we work. In this conversation, Dr. Mary E. Klotman, sits down with Dr. Christopher Lindsell, vice dean for data science and AI for the Duke University School of Medicine, to discuss Duke's vision for AI and data science.